Profilo
Alex Raeber worked as the Director of Global Research & Development at Thermo Fisher Scientific, Inc. He was also the Chief Scientific Officer & Executive Director at Benchmark Holdings Plc from 2018 to 2020.
Prior to that, he was the Head of Research & Development at Prionics AG from 2002 to 2011.
He worked as a Principal at both the University of California, Berkeley and the University of Zurich.
Raeber holds a doctorate from the University of Zurich and a graduate degree from the Swiss Federal Institute of Technology.
Precedenti posizioni note di Alex Raeber
Società | Posizione | Fine |
---|---|---|
BENCHMARK HOLDINGS PLC | Direttore Tecnico/Scientifico/R&S | 31/07/2020 |
THERMO FISHER SCIENTIFIC | Direttore Tecnico/Scientifico/R&S | - |
University of Zurich | Corporate Officer/Principal | - |
University of California, Berkeley | Corporate Officer/Principal | - |
Prionics AG
Prionics AG Medical SpecialtiesHealth Technology Prionics AG engages in the research in as well as the development, production, and distribution of diagnostic solutions for farm animal diseases. It focuses on diseases that can be transmitted from animals to human beings such as mad cow's disease and other prion diseases. The company was founded by Bruno Oesch and Markus Moser on February 27, 1997 and is headquartered in Schlieren, Switzerland. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Alex Raeber
Swiss Federal Institute of Technology | Graduate Degree |
University of Zurich | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
BENCHMARK HOLDINGS PLC | Health Technology |
THERMO FISHER SCIENTIFIC | Health Technology |
Aziende private | 1 |
---|---|
Prionics AG
Prionics AG Medical SpecialtiesHealth Technology Prionics AG engages in the research in as well as the development, production, and distribution of diagnostic solutions for farm animal diseases. It focuses on diseases that can be transmitted from animals to human beings such as mad cow's disease and other prion diseases. The company was founded by Bruno Oesch and Markus Moser on February 27, 1997 and is headquartered in Schlieren, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Alex Raeber